机译:血清sE-选择蛋白水平和外周血癌胚抗原mRNA表达细胞作为大肠癌患者的预后因素
Department of Laboratory Medicine and Advanced Biotechnologies, Scientific Institute for Research, Hospitalization and Health Care (IRCCS) San Raffaele, Rome, Italy;
|Scientific Institute for Research, Hospitalization and Health Care (IRCCS) San Raffaele, Rome, Italy|Division of Medical Oncology, Department of Internal Medicine, University of Rome “
Tor Vergata,”
Tor Vergata Clinical Center, Rome, Italy;
Department of Laboratory Medicine and Advanced Biotechnologies, Scientific Institute for Research, Hospitalization and Health Care (IRCCS) San Raffaele, Rome, Italy;
Department of Laboratory Medicine and Advanced Biotechnologies, Scientific Institute for Research, Hospitalization and Health Care (IRCCS) San Raffaele, Rome, Italy;
Division of Medical Oncology, Department of Internal Medicine, University of Rome “
Tor Vergata,”
Tor Vergata Clinical Center, Rome, Italy;
colorectal cancer; blood-borne cells; carcinoembryonic antigen; sE-selectin; metastasis;
机译:血清sE-选择蛋白水平和外周血中表达癌胚抗原mRNA的细胞是大肠癌患者的预后因素。
机译:抗原肽预加载的和固定的粘附性外周血细胞有资格从患有癌胚抗原的血清水平升高的癌症患者中诱导细胞毒性T淋巴细胞。
机译:根治性手术后7天检测外周血癌胚抗原信使RNA表达细胞是结直肠癌的一种新的预后因素。
机译:原发性乳腺癌患者术前血清CA15-3,CEA和TPS水平的临床和预后意义
机译:癌胚抗原(CEA)通过干扰TRAIL-R2(DR5)信号传导来抑制结直肠癌(CRC)细胞的失神经
机译:血清癌胚抗原水平对表皮生长因子受体敏感突变并接受酪氨酸激酶抑制剂的晚期非小细胞肺癌患者的预后和预测价值
机译:血清sE-选择蛋白水平和外周血癌胚抗原mRNA表达细胞作为大肠癌患者的预后因素